ADIM
VTRS icon

Alpha DNA Investment Management’s Viatris VTRS Stock Holding History

Alpha DNA Investment Management’s Portfolio VTRS Stock Details VTRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-79
Closed -$1K – 787
2020
Q4 		$1K Buy
+79
New +$1.29K ﹤0.01% 558

Other funds holding VTRS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Alpha DNA Investment Management's VTRS Position: Q1 2021 in Review

Alpha DNA Investment Management sold out of Viatris (VTRS) in Q1 2021, closing a stake of 79 shares — an estimated $1K sold.

Alpha DNA Investment Management first reported a position in VTRS in Q4 2020 and held it in 1 quarter. The position peaked at $1K in Q4 2020. 1,115 funds tracked by Wall St. Rank hold VTRS as of Q1 2021.

  • Alpha DNA Investment Management reported no remaining Viatris position as of Q1 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 79 Viatris shares in Q1 2021, an estimated $1K.
  • Alpha DNA Investment Management first reported a position in Viatris in Q4 2020 and held it in 1 quarter.
  • Alpha DNA Investment Management's Viatris position peaked at $1K in Q4 2020.
  • 1,115 funds tracked by Wall St. Rank held Viatris as of Q1 2021.

Based on Alpha DNA Investment Management's 13F filing for Q1 2021, filed 12 May 2021.